TP53 and cancer: The Pro72Arg variants of TP53 has been associated with various cancer susceptibility and poor outcomes [15], such as human papillomavirus 16-positive cervical cancer [16], laryngeal tumors [17], head and neck cancers [18], non-small cell lung cancer [19], and bladder cancer [20].